The impact of specific HIV treatment-related adverse events on adherence to antiretroviral therapy: a systematic review and meta-analysis.
The impact of specific HIV treatment-related adverse events on adherence to antiretroviral therapy: a systematic review and meta-analysis.
复制标题
DOI:
10.1080/09540121.2012.712667
复制
发表时间:
2013
期刊:
影响因子:
1.7
通讯作者:
Maiese EM
中科院分区:
文献类型:
--
作者:
Al-Dakkak I;Patel S;McCann E;Gadkari A;Prajapati G;Maiese EM
Poor adherence to antiretroviral therapies (ARTs) in human immunodeficiency virus (HIV)-infected patients increases the risk of incomplete viral suppression, development of viral resistance, progression to acquired immune deficiency syndrome and death. This study assesses the impact of specific treatment-related adverse events (AEs) on adherence to ART in the adult HIV patient population. A systematic review of studies involving adult HIV-infected patients aged ≥ 16 years that reported an odds ratio (OR) for factors affecting adherence to ART was conducted through a search of the EMBASE® and Medline® databases. Database searches were complemented with a search of titles in the bibliographies of review papers. Studies conducted in populations limited to a particular demographic characteristic or behavioural risk were excluded. To qualify for inclusion into a meta-analysis, treatment-related AEs had to be defined similarly across studies. Also, multiple ORs from the same study were included where study sub-groups were distinct. Random effects models were used to pool ORs. In total, 19 studies and 18 ART-related AEs were included in meta-analyses. Adherence to ART was significantly lower in patients with non-specific AEs than in patients who did not experience AEs [OR = 0.623; 95% confidence interval (CI): 0.465–0.834]. Patients with specific AEs such as fatigue (OR = 0.631; 95% CI: 0.433–0.918), confusion (OR = 0.349; 95% CI: 0.184–0.661), taste disturbances (OR = 0.485; 95% CI: 0.303–0.775) and nausea (OR = 0.574; 95% CI: 0.427–0.772) were significantly less likely to adhere to ART compared to patients without these AEs. Knowledge of specific treatment-related AEs may allow for targeted management of these events and a careful consideration of well-tolerated treatment regimens to improve ART adherence and clinical outcomes.
登录
查看更多内容
影响因子:
15.8
作者:
Mills EJ;Nachega JB;Bangsberg DR;Singh S;Rachlis B;Wu P;Wilson K;Buchan I;Gill CJ;Cooper C
通讯作者:
Cooper C
DOI:
10.1097/00042560-200205010-00014
发表时间:
2002-05-01
期刊:
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
影响因子:
--
作者:
de Olalla, PG;Knobel, H;Caylà, JA
通讯作者:
Caylà, JA
影响因子:
3.8
作者:
Bangsberg, DR;Perry, S;Moss, A
通讯作者:
Moss, A
DOI:
10.1097/00042560-200112150-00006
发表时间:
2001-12-15
期刊:
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
影响因子:
--
作者:
Ammassari, A;Murri, R;Antinori, A
通讯作者:
Antinori, A
影响因子:
11.8
作者:
Sethi, AK;Celentano, DD;Gallant, JE
通讯作者:
Gallant, JE